Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.055 | 0.8 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |